The Scientist

» stem cells and immunology

Most Recent

image: Stem-Cell Scientist Dies

Stem-Cell Scientist Dies

By | August 5, 2014

Yoshiki Sasai, a prominent organogenesis researcher who was a coauthor on two retracted stem cell studies, has died of apparent suicide at 52, officials say.

1 Comment

image: Aged Wisdom

Aged Wisdom

By | August 1, 2014

Supercentenarian Hendrikje van Andel-Schipper appeared on CNN in 2009, before donating her body to science and yielding insights into her remarkable longevity.

0 Comments

image: In Old Blood

In Old Blood

By | August 1, 2014

The body of a supercentenarian expands science’s appreciation for the physiological limits of aging.

3 Comments

image: Lawsuit Claims Stem Cells Unsafe

Lawsuit Claims Stem Cells Unsafe

By | July 18, 2014

A former employee complains that StemCells, Inc., fired him after he blew the whistle on improper manufacturing practices that could endanger patients.

0 Comments

image: Stem Cells for Autism?

Stem Cells for Autism?

By | July 15, 2014

Scientists express mixed enthusiasm over a trial to use cord blood stem cells as a treatment for autism.

0 Comments

image: Week in Review: June 30–July 4

Week in Review: June 30–July 4

By | July 4, 2014

STAP retractions; comparing SCNT-derived stem cells with iPSCs; malaria-infected mice more attractive to mosquitoes; stem cell banks face business challenges

0 Comments

image: Done with Immunosuppressants

Done with Immunosuppressants

By | July 3, 2014

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.

2 Comments

image: Not All Stem Cells Created Equal

Not All Stem Cells Created Equal

By | July 2, 2014

Compared to induced pluripotent stem cells generated from somatic cells, stem cells created by nuclear transfer appear to be closer to the genetic state of embryonic cells.

1 Comment

image: STAP Papers Retracted

STAP Papers Retracted

By | July 2, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Banking on iPSCs

Banking on iPSCs

By | June 30, 2014

A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham